Article

Glaucoma risk calculator helps with clinical decisions

A newly developed glaucoma risk calculator will enhance the management of untreated ocular hypertension, said Robert N. Weinreb, MD, director, Hamilton Glaucoma Center, and distinguished professor of ophthalmology, University of California, San Diego (UCSD).

The risk calculator was created by Felipe A. Medeiros, MD, assistant professor of ophthalmology, Dr. Weinreb, and colleagues at the Hamilton Glaucoma Center. Its development and validation testing are described in a recently published article [Medeiros FA, et al. Arch Ophthalmol 2005;123:1351-1360].

The risk assessment tool was designed to calculate the likelihood of progressing from ocular hypertension to glaucoma based on six clinical features that were identified as risk factors in the Ocular Hypertension Treatment Study (OHTS):

"Based on a multifactorial model used in cardiovascular medicine to assess the risk of a cardiovascular event and candidacy for lipid-lowering therapy, the glaucoma risk calculator was developed to integrate the risk factors identified in OHTS, so that clinicians could use them collectively to aid in identifying patients who should and should not be considered for IOP-lowering treatment," he continued.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
I. Paul Singh, MD, speaks about glaucoma treatment and successful ophthalmic / optometric comanagement at the 19th Annual Controversies in Modern Eye Care meeting
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
© 2025 MJH Life Sciences

All rights reserved.